{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:40:15Z","timestamp":1756276815130,"version":"3.44.0"},"reference-count":14,"publisher":"BMJ","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DTB"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:p>Many women develop male-pattern facial hair (facial hirsutism), which can be distressing and difficult to treat. \u25bcEflornithine (Vaniqa \u2013 Shire) is a topical cream available only on prescription for treating women with facial hirsutism. Promotional material claims that the treatment \u201cslows facial hair growth \u2013 grows her confidence\u201d. Does this product have a place in the management of women with hirsutism?<\/jats:p>","DOI":"10.1136\/dtb.2007.45862","type":"journal-article","created":{"date-parts":[[2008,7,18]],"date-time":"2008-07-18T16:15:40Z","timestamp":1216397740000},"page":"62-64","source":"Crossref","is-referenced-by-count":1,"title":["Does \u25bceflornithine help women face hirsutism?"],"prefix":"10.1136","volume":"45","member":"239","published-online":{"date-parts":[[2007,8,1]]},"reference":[{"key":"2025082623065662000_45.8.62.1","first-page":"995","article-title":"The evaluation and management of hirsutism.","volume":"101","author":"Azziz","year":"2003","journal-title":"Obstet Gynecol"},{"key":"2025082623065662000_45.8.62.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(02)02725-4"},{"key":"2025082623065662000_45.8.62.3","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-21-11-1440"},{"key":"2025082623065662000_45.8.62.4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2301"},{"key":"2025082623065662000_45.8.62.5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2265.1994.tb02535.x","article-title":"A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia.","volume":"41","author":"O\u2019Driscoll","year":"1994","journal-title":"Clin Endocrinol"},{"key":"2025082623065662000_45.8.62.6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpsychores.2006.01.016","article-title":"Women living with facial hair: the psychological and behavioral burden.","volume":"61","author":"Lipton","year":"2006","journal-title":"J Psychosomatic Res"},{"key":"2025082623065662000_45.8.62.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2006.01.016"},{"key":"2025082623065662000_45.8.62.8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome.","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol"},{"key":"2025082623065662000_45.8.62.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb02909.x"},{"key":"2025082623065662000_45.8.62.10","doi-asserted-by":"publisher","DOI":"10.1177\/00912700122010951"},{"key":"2025082623065662000_45.8.62.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2006.03079.x"},{"key":"2025082623065662000_45.8.62.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.09.025"},{"key":"2025082623065662000_45.8.62.13","unstructured":"Committee for Proprietary Medicinal Products (CPMP). European Public Assessment Report Vaniqa. London: European Agency for the Evaluation of Medicinal Products, 2004 [online]. Available: http:\/\/www.emea.eu.int\/humandocs\/Humans\/EPAR\/vaniqa\/vaniqa.htm [Accessed 11 July 2007]."},{"key":"2025082623065662000_45.8.62.14","unstructured":"Scottish Medicines Consortium. Eflornithine 11.5% cream (Vaniqa\u00ae) Resubmission The Scottish Medicines Consortium issues advice on eflornithine 11.5% cream (Vaniqa\u00ae) for the treatment of facial hirsutism in women [online]. Available: http:\/\/www.scottishmedicines.org.uk\/smc\/smc_display.jsp?pContentID\u200a=\u200a3998&p_applic\u200a=\u200aCCC&p_service\u200a=\u200aContent.show& [Accessed 11 July 2007]."}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2007.45862","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:07:06Z","timestamp":1756274826000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2007.45862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":14,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2007,8,1]]},"published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1136\/dtb.2007.45862"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2007.45862","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}